Octaplas FDA Approval History
Last updated by Judith Stewart, BPharm on May 19, 2020.
FDA Approved: Yes (First approved January 17, 2013)
Brand name: Octaplas
Generic name: pooled plasma (human)
Dosage form: Solution for Intravenous Infusion
Treatment for: Bleeding Disorder
Octaplas is a solvent/detergent (S/D) treated, pooled human plasma indicated for the replacement of multiple coagulation factors in patients with acquired deficiencies and plasma exchange in patients with thrombotic thrombocytopenic purpura.
Development Timeline for Octaplas
|Jan 17, 2013||Approval FDA Approves Octaplas to Treat Patients with Blood Clotting Disorders|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.